Enhanced Virulence of Chlamydia muridarum Respiratory Infections in the Absence of TLR2 Activation by He, Xianbao et al.
Enhanced Virulence of Chlamydia muridarum
Respiratory Infections in the Absence of TLR2 Activation
Xianbao He
1, Anjali Nair
1, Samrawit Mekasha
1, Joseph Alroy
2, Catherine M. O’Connell
3, Robin R.
Ingalls
1*
1Section of Infectious Diseases, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, United States of America, 2Department of
Pathology, Tufts University School of Medicine, Cummings School of Veterinary Medicine, and Tufts Medical Center, Boston, Massachusetts, United States of America,
3Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States of America
Abstract
Chlamydia trachomatis is a common sexually transmitted pathogen and is associated with infant pneumonia. Data from the
female mouse model of genital tract chlamydia infection suggests a requirement for TLR2-dependent signaling in the
induction of inflammation and oviduct pathology. We hypothesized that the role of TLR2 in moderating mucosal
inflammation is site specific. In order to investigate this, we infected mice via the intranasal route with C. muridarum and
observed that in the absence of TLR2 activation, mice had more severe disease, higher lung cytokine levels, and an
exaggerated influx of neutrophils and T-cells into the lungs. This could not be explained by impaired bacterial clearance as
TLR2-deficient mice cleared the infection similar to controls. These data suggest that TLR2 has an anti-inflammatory function
in the lung during Chlamydia infection, and that the role of TLR2 in mucosal inflammation varies at different mucosal
surfaces.
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Introduction
Chlamydia trachomatis is the most common bacterial sexually
transmitted pathogen worldwide [1], and the etiologic agent of
blinding trachoma [2]. Complications of infections in women
include the development of pelvic inflammatory disease, which can
lead to tubal infertility and chronic pelvic pain. Infants born to
women with active cervical chlamydia infection are at risk of
developing conjunctivitis and pneumonia [3,4]. While the
induction of an inflammatory immune response is clearly essential
for the survival of a host following an infectious challenge, it is also
true that an exaggerated inflammatory response can be detrimen-
tal, as in the case of severe sepsis and some autoimmune chronic
inflammatory states. Likewise, the pathology associated with
genital chlamydia infection and ocular trachoma is thought to
result from bystander injury during an aggressive inflammatory
response. Thus, proinflammatory pathways must be tightly
regulated.
The interaction of Chlamydia with innate immune receptors
expressed at mucosal surfaces likely triggers the initial wave of
proinflammatory mediators, which in turn recruit additional
inflammatory cells, leading to further modulation of the immune
response. The inflammatory pathways utilized by Chlamydia
appear to primarily involve TLR2, and a number of studies have
shown a dependence on expression of TLR2 in cellular activation
byC.trachomatis invitro[5,6,7,8].However,theTLR2ligandremains
unidentified, although lipoproteins expressed in the outer mem-
brane of the organism are likely candidates [5]. Chlamydia species
also express lipopolysaccharide (LPS) in the outer membrane, a
recognized ligand for TLR4. However, unlike enteric LPS
preparations, which are some of the most potent inducers of
inflammation known, chlamydia LPS is of low endotoxic activity,
and appears to be more dependent on membrane CD14 than has
been reported for other species of LPS [9,10,11]. In addition,
Chlamydia has been reported to activate type I interferon signaling
in a TLR2- independent manner, possibly via a yet unidentified
cytosolic DNA sensor [12].
Several small animal models exist for studying the pathogenesis
of chlamydia infections. Significant data has been gathered from
the female mouse model of ascending genital tract infection that
closely parallels C. trachomatis infections and pelvic inflammatory
disease in humans. When inoculated intravaginally into mice, C.
muridarum, the mouse biovar of C. trachomatis (formerly known as
MoPn), establishes an active infection of the endocervix, then
ascends to the upper genital tract where it infects the oviducts.
Consequences of oviduct infection in the mouse include dilatation
(hydrosalpinx) and infertility [13,14,15]. In addition to being used
in a model for genital tract infections, C. muridarum is a respiratory
pathogen in mice, and produces pneumonia following intranasal
inoculation [16]. In vivo data using TLR2-deficient mice [6]
demonstrates an association between TLR2 expression and the
development of inflammation and oviduct pathology following
genital tract challenge with C. muridarum in the mouse model.
While the bacterial burden and course of infection in the genital
tract is unchanged in the absence of TLR2, expression of
proinflammatory cytokines and chemokines in the genital tract is
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Similar results were obtained when mice were challenged with
plasmid-cured mutants of C. muridarum that fail to activate TLR2
[17]. No studies to date have monitored the course of infection in
the absence of TLR2 following respiratory challenge with C.
muridarum.
We hypothesized that the role of TLR2 in regulating mucosal
inflammation varies depending on the specific site. In order to
determine the role of TLR2 signaling at the respiratory mucosal
surface, we infected wild type and TLR2-deficient mice with C.
muridarum. We found that while both mouse strains cleared the
infection over time in a similar manner, the disease was more
severe in TLR2-deficient mice, and these mice developed
significantly higher lung cytokine levels with exaggerated neutro-
phil and T-cell influx in the lungs. Similar results were obtained
when wild type mice were infected with plasmid-cured mutants of
C. muridarum that fail to activate TLR2. Thus, our data suggests
that TLR2 plays an important anti-inflammatory role in the lung
during respiratory infection with Chlamydia.
Materials and Methods
Reagents
LPS (Escherichia coli serotype O111:B4) was purchased from
List Biological Laboratories, INC (Campbell, CA); RPMI-1640
was purchased from BioWhittakerH (Lonza Walkersville, MD).
Fetal Bovine Serum (FBS) was from Hyclone (Logan, Utah).
Renografin-60 was purchased from Bracco Diagnostics Inc.
(Princeton, NJ).
Bacterial preparation
Chlamydia muridarum strains Nigg (wild type) and plasmid-cured
strains CM 972 and CM 3.1 have been previously described
[8,17,18]. Chlamydiae were propagated in L929 fibroblasts
growing in RPMI medium supplemented with 10% FBS at
37uC in a 5% CO2 environment. Following 42 to 45 hours of
infection, cells were harvested, disrupted by glass beads or
sonication (Sonicator 4000, Misonix Sonicators, Newtown, CT),
and chlamydiae were separated from cell debris by ultracentrifu-
gation through 32% Renografin. Chlamydial EBs were further
purified by ultracentrifugation on a discontinuous Renografin
gradient. After washing twice, the EB pellets were suspended in
SPG (sucrose–phosphate–glutamate buffer, pH 7.2) and stored at
280uC prior to use. Bacterial titers were calculated as inclusion
forming units (IFU) per ml. The stocks of C. muridarum strains used
in this study were negative for Mycoplasma sp. by PCR [19].
Mice
C57BL/6J mice were purchased from Jackson Laboratory (Bar
Harbor, ME). TLR2-deficient mice generated by targeted deletion
of mouse tlr2 have been previously published [20] and were used
with permission from Dr. Shizuo Akira. A colony of TLR2-
deficient mice, back bred at least 10 generations on the C57BL/6
background, was maintained in our animal facility for use in these
studies. All animals were housed in groups of 3–5 mice per cage in
a controlled environment (temperature 20–22uC; 12:12 hours
light:dark cycle), given free access to food and water, and
maintained under the supervision of veterinary staff from the
Laboratory Animal Science Center at Boston University Medical
Center. All experimental procedures were carried out with
approval from the Institutional Animal Care and Use Committee
and the Institutional Biosafety Committee at Boston University
Medical Center (Animal Welfare Assurance number A-3316-01).
Preparation of alveolar macrophages and bone marrow
derived macrophages
Alveolar macrophages (AM) were prepared from C57BL/6 and
TLR2-deficient mice by bronchoalveolar lavage (BAL). Briefly,
groups of 6–8 mice aged 6 to 8 weeks were euthanized by CO2
inhalation and the intact lungs lavaged with ,1 ml of Hank’s
Balanced Salt Solution (HBSS). Collected AM were pooled and
washed with PBS, then plated at 1.5610
5 cells/well on 48-well
plates. Bone marrow derived macrophages (BMDM) were
prepared from mice as follows. The bone marrows of femurs
and tibiae from mice aged 6–8 weeks were flushed with
RPMI1640 supplemented 10% FBS, 20 mg/ml gentamicin. The
recovered cells were cultured in RPMI 1640 supplemented with
10% FBS, 20 mg/ml gentamicin, with 20–30% (v/v) of L929
conditioned medium (containing M-CSF) and incubated at 37uC,
5% CO2 for 7–9 days to facilitate macrophage differentiation
before being infected with C. muridarum. Cells were inoculated with
C. muridarum as described below.
In vitro infection of cells with C. muridarum
Macrophages were seeded on tissue culture plates and rested
overnight. The following day cells were inoculated with C.
muridarum at the indicated multiplicity of infection (MOI). The
plate was then centrifuged at 3000 rpm, 35uC for 1 h; this point
was then considered as the 0 h time point. The inoculated
macrophages were then incubated at 37uC, 5% CO2. At the
designated time points, supernatant was collected and cells were
washed twice with PBS, and then detached in 100 ml SPG and
stored at 280uC for quantitative chlamydial culture.
Murine intranasal infection model
Groups of 6–8 male or female mice aged 6 to 8 weeks were
inoculated intranasally under light anesthesia using ketamine/
xylazine mix (60–100/5–10 mg/kg i.p.). All infected mice received
20 ml bacterial suspension in phosphate buffered saline (PBS)
containing 5610
3 IFU gradient purified chlamydiae unless
otherwise noted in the text; mock infected mice received 20 ml
of SPG diluted in PBS. Mice were weighed daily and observed for
signs of distress that would require early euthanasia. At the
indicated time points, mice were euthanized by CO2 inhalation.
Lung tissue was process in one of two ways. For lung cytokines,
flow cytometry and bacterial quantitation, lungs were homoge-
nized in PBS using a Medimachine System (BD Biosciences, San
Jose, CA). For histopathology and immunohistochemistry, lungs
were inflated with 10% neutral formalin via the trachea, removed
en bloc for further formalin fixation, and embedded in paraffin.
Spleen homogenates were prepared in a similar fashion. All
experiments involving mice were carried out with approval from
the Institutional Biosafety Committee and the Institutional Animal
Care and Use Committees at Boston University Medical Center.
All in vivo experiments were repeated two to three times, as noted
in the text.
Quantification of C. muridarum
Bacterial load was determined by both quantitative culture and
quantitative PCR. For culture of tissue, 150 ml of SPG was added
to 50 ml of tissue homogenate, mixed, and briefly spun to pellet
tissue debris. Serial dilutions were inoculated in duplicate onto
L929 fibroblasts seeded to confluence in a 96-well plate. After
incubation for 24–35 h at 37uC, 5% CO2, the cells were fixed with
ice-cold methanol. Chlamydial inclusions in infected cells were
detected using a Chlamydia-specific LPS monoclonal antibody
(gift of Dr. You-Xun Zhang, Boston Medical Center), followed by
Site-Specific Role of TLR2 in Chlamydia Infections
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with Evans blue (Sigma). The inclusions were counted under
fluorescent microscopy, and calculated as the number of IFU per
well/per lung.
Quantitative PCR was carried out from the same homogenates
as follows: Genomic DNA was extracted from 5 ml of sample by
addition to 195 ml of QuickExtract (Epicentre; Madison WI) and
processed according to the manufacturer’s instructions. The
sample extracts were further diluted 1:100 before being assayed
via quantitative RT-PCR using primers directed against the 16S
gene [21]. Genome equivalents per sample were extrapolated from
a standard curve with adjustment for the presence of two copies of
16S on the C. muridarum genome.
Detection of cytokines and chemokines
Lung homogenates and cell culture supernatants were assayed
for cytokines and chemokines by individual ELISA and/or
Milliplex 22-plex multiplex assay (Millipore Corp.; Billerica,
MA), according to the manufacturer’s instructions. ELISA kits
for mouse IP-10 and TNF-a were purchased from R&D Systems
(Minneapolis, MN) and eBioscience (San Diego, CA), respectively.
ELISA plates were read in an ELx800 Universal Microplate
Reader (BIO-TEX Instrument Inc.) and multiplex assays were run
on the LiquiChip 200 Workstation (Qiagen, Valencia, CA). Each
sample was assayed in triplicate (single ELISA) or duplicate
(Multiplex), and p-values were calculated using an unpaired t-test.
All in vitro studies were repeated at least three times.
Flow cytometric analysis
Lung homogenates were digested in HEPES buffer (10 ml
HEPES pH7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2,
1.8 mM CaCl2), containing collagenase D and DNase I at room
temperature for 15 minutes and homogenized using a Medima-
chine System. A single-cell suspension was obtained by filtering the
cells through a 70 mm mesh cell strainer. After lysis of the
erythrocytes using RBC Lysis Buffer (eBioscience), cells were
blocked using 1 mg goat IgG per ml, and incubated on ice with
antibody at a final concentration of 0.5 mg/ml in phosphate
buffered saline containing 1% fetal bovine serum for 30 minutes.
The following directly conjugated fluorescent Abs were used for
FACS analysis in these studies: F4/80-PE-Cy5 (clone BM8, from
eBioscience) for the detection of macrophages; Ly-6G (Gr-1)-PE-
Cy5 (clone RB6.8C5, from eBioscience) for the detection of
neutrophils; CD19-PE (clone 6D5) and CD3-RPE (clone
C363.29B; both from Southern Biotech, Birmingham, AL) for
detection of B-cells and T-cells, respectively. Labeled cells were
analyzed by flow cytometry using a fluorescence-activated cell
sorter (FACScan) microfluorimeter (BD Biosciences) and analyzed
using FlowJo software (Ashland, OR).
Histopathology and immunohistochemical analysis
Following euthanasia, lungs were inflated with 10% neutral
formalin via the trachea, removed en bloc for further formalin
fixation, and embedded in paraffin. Lungs were cut completely in
7–8-mm sections, and every 10th section was stained with
hematoxylin and eosin (H&E). For quantification of PMNs in
lungs, chloroacetate esterase (CAE) stain was performed and
PMNs were counted using ImageJ software. At least 10 fields were
randomly reviewed from each lung. Immunohistochemistry was
carried out on deparaffinized tissue that was stained with
monoclonal antibodies recognizing mouse CD19 (clone MRQ-
36; Cell Marque Corporation) vimentin (clone V9; Ventana), or
their respective isotype controls, followed by an appropriate
secondary antibody with horseradish peroxidase for detection. All
slides were reviewed by a veterinary pathologist who was blinded
as to the experimental design.
Statistics
Significant differences for the in vivo studies were determined as
follows. Statistical comparisons between the mouse strains for
weight loss over the course of infection were made by a two-factor
(days and mouse strain) repeated measures ANOVA with post hoc
Bonferroni test. Statistical comparisons were made between
murine strains for infectious burden at the time of euthanasia
using a Mann-Whitney U test. Significant differences for the in vitro
studies were determined using a two-tailed t-test. GraphPad Prism
software was used for all statistical analyses.
Results
TLR2 expression is required for the induction of some
inflammatory cytokines by macrophages in vitro in
response to C. muridarum infection
Macrophages play a key role in the induction of a variety of
proinflammatory cytokines, and they are rapidly recruited to
mucosal surfaces along with other professional immune cells during
infectious challenges. We first examined bone marrow derived
macrophages from C57BL/6 vs. TLR2-deficient mice on the same
background for induction of various cytokines in response to
productive infection with C. muridarum. We observed the induction
of cytokines such as TNF-a was largely dependent on expression of
TLR2 (Fig. 1A), while a subset of cytokines, including IP-10, were
TLR2 independent (Fig. 1B). The presence of resident macro-
phages is a unique property of the lung. We compared alveolar
macrophages (AM) prepared from the lungs of control and TLR2-
deficient mice with BMDM derived from the same mice to
determine if alveolar macrophages differed in their response to
chlamydia infection. We found TLR2 expression was also required
for the induction of TNF-a by AM, (Fig. 1C) although when
compared withBMDM, the absolute concentration is lower and the
peak is markedly delayed. Thus, we anticipated that in vivo cytokine
induction following intranasal challenge would also be largely
TLR2-dependent, as has been observed in the genital tract [6].
Disease following intranasal challenge is more severe in
TLR2-deficient mice
Intranasal infection of mice with C. muridarum is a well-
established model for chlamydia-induced pneumonia. Previous
studies have demonstrated that immune competent mice have
peak bacterial burden at around 7 days post infection followed by
bacterial clearance, and that IFN-c and IL-12 are required for
resolution of infection and protective immunity [22,23]. To
determine the role of TLR2 expression during respiratory
infection with C. muridarum, we infected C57BL/6 and TLR2-
deficient mice on the same background intranasally with a
sublethal dose of bacteria (5610
3 IFU per mouse), and monitored
for weight loss and survival. All infected mice, regardless of TLR2
expression, survived intranasal challenge, and while there was a
trend towards exaggerated weight loss in the TLR2 deficient mice,
it did not reach statistical significance (data not shown). However,
when mice were challenged with a high inoculum of bacteria
(2.5610
4 IFU per mouse), TLR2-deficient mice did show more
exaggerated body weight loss over time compared to control
C57BL/6 mice, particularly during the latter half of the course of
infection, between days 5–9, suggesting more severe disease
(Fig. 2A). Despite having more severe disease, we observed no
difference in the peak bacterial burden or duration of infection
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e20846Figure 1. Cytokine induction in wild type vs. TLR2-deficient macrophages. (A) BMDM from C57BL/6 or TLR2 KO mice on the same
background were left untreated, or infected with the indicated MOI of C. muridarum Nigg (Cm). Synthetic lipopeptide Pam3Cys-Ser-Lys4 (Pam3;
100 ng/ml) or LPS was used as a control. The supernatants were harvested at 24 hr post treatment and assayed for TNF-a and IP-10 by ELISA. The
values showed are the mean 6 SEM from triplicate samples. (B) BMDM and alveolar macrophages (AM) from C57BL/6 or TLR2 KO mice on the same
background were infected with C. muridarum Nigg at MOI of 3:1. LPS (100 ng/ml) was used as control. The supernatants were harvested at
the indicated time points and assayed for TNF-a by ELISA. Significance was calculated as follows using a two-tailed t-test: *, p#0.05; **, p#0.01;
***, p#0.001; ****, p#0.0001.
doi:10.1371/journal.pone.0020846.g001
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(Fig. 2B and data not shown). The bacterial burden for infected
C57BL/6 and TLR2-deficient mice peaked between days 2–4,
and while there was a trend towards higher bacterial burden at
day 4 in the TL2-deficient mice, it did not reach statistical
significance.
Infected TLR2-deficient mice develop higher
inflammatory cytokine levels and more severe lung
inflammation compared to wild-type mice when
challenged via the intranasal route
The trend towards increased weight loss following challenge
that we observed in the TLR2-deficient mice suggested that they
might have suffered more severe inflammation during the course
of infection compared to the controls. Indeed, when we examined
lung homogenates from infected mice at various points in time,
we found that nearly all of the cytokines and chemokines tested,
were increased in the infected TLR2-deficient mice relative to the
control mice (Fig. 3 and data not shown). This included classic
proinflammatory cytokines, such as TNF-a, IL-6, and chemo-
kines, such as MCP-1 and IP-10. Moreover, IFN-c, IL-12 and IL-
17, which have been shown to be required for bacterial clearance,
were also elevated in the TLR2-deficient mice, possibly
facilitating resolution of the infection in spite of more severe
disease. Thus, in contrast to the in vitro infection, TLR2
expression was not required for the induction of cytokines in vivo
following intranasal challenge.
Figure 2. Weight change and bacterial clearance of C. muridarum infected wild type vs. TLR2-deficient mice. C57BL/6 or TLR2 KO mice
on the same background were intranasally inoculated with PBS (mock; N=6) or 2.5610
4 IFU/mouse of C. muridarum Nigg (N=8), as described in the
Methods. (A) Mice were weighed daily for 9 days post infection. Shown above is the weight change relative to the starting weight of each individual
mouse (weight day X/weight day 0). Significance is as follows: p=0.0474 infected BL/6 vs infected TLR2 KO over time, using RM ANOVA as described
in the methods using a two-factor RM ANOVA with post hoc test. No significant difference in weight was observed between uninfected strains. (B)
Mice were infected with 5610
3 IFU C. muridarum Nigg, and were euthanized on day 2, 4, 7, 14 and day 20. Quantitative bacterial cultures were
determined from whole lung homogenates, as described in the Methods. Quantitative culture data was confirmed by quantitative PCR (data not
shown). Statistical analysis of the infectious burden over time using a Mann-Whitney U test was not significant. This figure is representative of three
independent experiments performed.
doi:10.1371/journal.pone.0020846.g002
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Both control and TLR2-deficient mice developed a patchy
pneumonia, with inflammatory exudates visible in the alveolar
space. As shown in figure 4, histological examination of lungs from
infected mice by routine H&E staining at day 7 post infection
revealed various size foci of pneumonia. In some of the foci the
alveoli are packed with neutrophils, while in other foci the alveoli
contained only few neutrophils but had proliferating fibroblasts.
Overall, the TLR2-deficient mice had more severe neutrophilic
infiltration while the wild type C57BL/6 mice displayed more
prominent fibroblast proliferation, suggesting superior repair
(Fig. 4A, 4B). PMN infiltration from infected mouse lungs was
quantified, and is shown in Fig. 5A. Consistent with this
observation, only lung tissue from the wild type mice stained for
the intermediate filament vimentin at 5 days post infection
(Fig. 4E, 4F), although by day 14 vimentin staining was similar in
both mouse strains (data not shown). By 14 days post infection,
inflammation was still visible in the TLR2-deficient mice while
inflammation was largely resolved in the wild type mice (Fig. 4C,
4D). Moreover, in more than half of the TLR2-deficient mice, we
observed prominent, well-developed bronchus associated lym-
phoid tissue (BALT) containing CD19-expressing B lymphocytes
at 5 days post infection, consistent with inducible BALT (iBALT)
(Fig. 4G, 4H). In contrast, while there were a few areas of poorly
developed lymphoid aggregates seen in one of the C57BL/6 mice,
it did not develop into the prominent BALT seen in the knockout
mice (data not shown).
To confirm the observation that TLR2-deficient mice experi-
enced more severe lung inflammation in response to their
infection, we examined the recruitment of neutrophils and
macrophages to the lung using flow cytometry. Lungs from
infected mice were removed at 7 days post-infection, digested to
obtain a single cell suspension, and stained for expression of GR1,
a marker for neutrophils, F4/80, a marker for macrophages,
CD19, a marker for B-cells, and CD3, a marker for T-cells. As
shown in Fig. 5B, we found that TLR2-deficient mice had a
significantly higher percent of infiltrating neutrophils and T-cells
in the lungs when compared to control mice. Elevated levels of
macrophages were also detected in these mice. Interestingly, B-
cells appeared to be decreased in response to infection in the
TLR2-deficient mice compared to wild type mice when analyzed
by this method, although, as noted above, immunohistochemistry
demonstrated the formation of B-cell aggregates into areas of
BALT.
Plasmid-cured strains of C. muridarum induce more
inflammation compared to wild-type strain when
inoculated via the intranasal route
We previously described two plasmid-deficient C. muridarum
Nigg strains, CM 972 and CM 3.1, which are impaired in their
ability to activate TLR2 in vitro and in the murine genital tract
infection model. Moreover, mice infected with these plasmid-
cured strains fail to develop oviduct pathology in vivo [17]. Based
on our data with the TLR2-deficient mice, we hypothesized that
these mutants, although attenuated when inoculated in the genital
tract, would display enhanced virulence when inoculated via the
intranasal route. Indeed, we observed striking differences between
mice infected with the wild type plasmid-containing Nigg strain
Figure 3. Intranasal infection of TLR2-deficient mice with C. muridarum induces more exaggerated lung inflammatory cytokine
response compared to infected wild type mice. C57BL/6 or TLR2 KO mice on the same background were intranasally inoculated with PBS
(mock) or 5610
3 IFU/mouse of C. muridarum Nigg, as described in the Methods. At seven days post infection, lung homogenates were assayed for a
panel of 22 inflammatory cytokines and chemokines. Shown above are representative results for 6 of the cytokines assayed. Each data point
represents one mouse, and the horizontal bar represents the mean. Significance was calculated as follows using a two-tailed t-test: **, p#0.01 and
***, p#0.001 for the infected C57BL/6 vs. infected TLR2-deficient mice. NS, not significant. This figure is representative of three independent
experiments performed.
doi:10.1371/journal.pone.0020846.g003
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PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e20846Figure 4. Intranasal infection with C. muridarum induces more extensive inflammatory changes in the lungs of TLR2-deficient mice
compared to wild type mice. C57BL/6 or TLR2 KO mice on the same background were intranasally inoculated with PBS (mock) or 5610
3 IFU/
mouse of C. muridarum Nigg. At the indicated time points, mice were euthanized and lungs were removed for tissue processing, as described in the
Methods. A–D and G show routine H&E staining; P=dense PMN infiltrate, shown as deep purple-staining cells. E–F and H show vimentin and CD19
staining by immunohistochemistry, respectively. (A) C57BL/6, day 7; (B) TLR2-deficient, day 7; (C) C57BL/6, day 14; (D), TLR2-deficient, day 14. (E–F)
Lungs from infected TLR2-deficient mice (F) fail to stain for vimentin (V) at 5 days post infection compared to C57BL/6 mice (E). (G–H) Lungs from
infected TLR2-deficient mice show evidence of iBALT (*) at 7 days post infection when stained with H&E (G) or anti CD19 Ab to detect CD19-
expressing B cells (H). Original magnification 406. This figure is representative of three independent experiments performed.
doi:10.1371/journal.pone.0020846.g004
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mutants. Mice infected with CM 972 or CM 3.1 strains were
subjectively more ill-appearing compared to the Nigg-infected
mice, and while there was a trend towards more exaggerated
weight loss in the plasmid-cured infected mice, it did not reach
statistical significance (data not shown). Upon histological
examination, the lungs from all infected mice displayed evidence
of pneumonia that was characterized by the presence of edema,
with alveolar infiltration by neutrophils. However, mice infected
with either CM 972 or CM 3.1 were grossly more edematous and
necrotic when compared with the Nigg-infected mice (data not
shown), and upon histologic examination they displayed signifi-
cantly more interstitial edema and more extensive parenchymal
involvement (Fig. 6). Furthermore, the CM972 and CM3.1
infected mice displayed significantly increased lung cytokines and
chemokines compared to Nigg infected mice (Fig. 7 and data not
shown), although we observed no difference in bacterial clearance
at 7 and 14 days post-infection (data not shown). These data
resembled the results obtained from TLR2-deficient mice, and
suggested that the inability of the plasmid-cured strains to activate
TLR2-dependent signaling pathways led to an exaggerated
inflammatory response in the lung. Thus, while the presence of
the plasmid enhances chlamydial virulence in the genital tract it
has the opposite effect in lung.
Discussion
Mucosal surfaces are important sites of tolerance and infection
in the respiratory, urogenital and gastrointestinal tracts and there
is a growing interest in the development of vaccines capable of
inducing both mucosal and systemic immunity in the fight against
a variety of pathogens. However, immune defenses in these
complex and unique mucosal compartments are not identical, and
careful studies are needed to characterize the defense responses
specific to each site. The murine pathogen, C. muridarum, provides
an opportunity to compare innate immune defenses at two
different mucosal sites because it infects both the genital tract and
the lung of mice. Thus, inflammatory differences identified in our
study between the lung and the genital tract may be ascribed to the
site-specific immune response rather than the pathogen.
We observed that in the absence of TLR2 expression, mice had
more severe disease when inoculated with C. muridarum via the
intranasal route, with TLR2-deficient mice demonstrating more
severe weight loss as well as a more exaggerated and prolonged
inflammatory response in the lungs, as demonstrated by increased
lung cytokines and cellular inflammatory cell infiltrate. The
observation of enhanced induction of BALT in the lungs of TLR2-
deficient mice is consistent with the overall exaggerated inflam-
matory response observed, as iBALT has been shown to develop in
response to infection or chronic inflammation [reviewed in [24]].
Interestingly, mice infected with plasmid-cured strains of chla-
mydia that fail to activate TLR2 displayed a similarly exaggerated
inflammatory response. Thus, TLR2 activation in the lung
appears to be necessary for moderation of the inflammatory
response both with regard to attenuating the induction of
inflammatory cytokines and the inflammatory cellular response.
This is the opposite of what has been observed in the genital tract
where TLR2 activation is required for peak cytokine induction
and the subsequent development of oviduct pathology [6,17]. We
do not believe that gender differences account for the difference in
the host inflammatory response between mucosal sites, as we used
both male and female mice in the lung infection model and we
observed no significant difference in the clinical course and
cytokine induction between male and female mice (data not
shown). Instead, we believe that the role of TLR2 in driving
inflammation and pathology at the two mucosal sites differs, likely
driven by differences in the cellular composition and physiologic
roles of the specific tissues.
The explanation for enhanced inflammation in the lung in
response to chlamydial infection in the absence of TLR2
expression does not appear to be explained by impaired bacterial
clearance or increased bacterial load because both wild type and
TLR2-deficient mice displayed identical kinetics with regard to
clearance of the infection. This observation was consistent with
Figure 5. TLR2 deficiency leads to exaggerated PMN and T cell
response in the lungs of C. muridarum infected mice. C57BL/6 or
TLR2 KO mice on the same background were intranasally inoculated
with 5610
3 IFU/mouse of C. muridarum Nigg. At the indicated day post
infection, lungs from infected mice were processed to evaluate
inflammatory cell infiltrates. (A) At day 5 and day 7 post-infection,
lungs were fixed, sectioned and stained using CAE to quantify the PMN
infiltration, as described in the Methods. Significance was calculated
using an unpaired t-test, and the p-value is noted. (B) Single-cell
suspensions of infected lungs at day 7 were prepared, stained, and
analyzed by flow cytometry, as described in the Methods. F4/80-PE Cy5
was used as a marker for macrophages; Gr-1-PE Cy5 for neutrophils;
CD19-PE for B lymphocytes and CD3-PE for T lymphocytes. The bar
graph represents the percentage of positive cells from total lung cells,
as determined by histogram data. Significance is as follows: *, p#0.05;
**, p#0.01 for the infected C57BL/6 vs. infected TLR2-deficient mice
using an unpaired t-test. This figure is representative of two
independent experiments performed.
doi:10.1371/journal.pone.0020846.g005
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expression is not necessary for clearance of the bacterial infection
at that site as well [6]. However, it is possible that a transiently
elevated bacterial load in the TLR2-deficient mice compared to
the wild type mice that we could not detect might expose the tissue
to other TLR ligands, thus driving inflammation. Others have
reported an essential role for IL-17 and Th17 responses in the
protection of mice against respiratory infection with C. muridarum
[25,26,27]. However, we found no evidence of impaired IL-17
production in the TLR2-deficient mice that could explain the
more severe infection. In fact, we observed an enhanced IL-17
response in the lung, which would be consistent with the
exaggerated neutrophil response we also observed. Moreover,
the induction of IL-10, an anti-inflammatory cytokine, was not
impaired in the absence of TLR2 signaling.
One possible mechanism for our observation that TLR2-
deficient mice developed exaggerated PMN response in the lung
involves altered alveolar macrophage function. Alveolar macro-
phages have long been known to play an important role in the
resolution of inflammation in the lung by virtue of their ability to
phagocytose and clear apoptotic PMNs [28]. Given that
Chlamydia-infected TLR2-deficient macrophages were impaired
in their ability to secrete proinflammatory cytokines, they might
also be impaired in their ability to clear PMNs from the lung, thus
allowing inflammation to persist for longer. In addition, it was
recently reported that engagement of TLR2 promotes the survival
of regulatory T-cells [29], which might also be important in
turning off inflammation in the lung. Regarding the observed
differences between the lung and genital tract mucosal responses to
the same pathogen, further studies are needed to determine
whether differences in the expression of TLR2 on cell types that
are specific to these two compartments might account for the
differential role of TLR2 in inflammation in different tissues.
A protective role for TLRs in respiratory infections has been
reported for a number of pathogens. For example, TLR4-deficient
mice were found to be incapable of controlling Gram-negative
respiratory infections secondary to Klebsiella pneumoniae [30],
Haemophilus influenzae [31], and Pasteurella pneumotropica [32,33].
Likewise, TLR2-deficient mice were recently reported to have
more severe mycoplasma respiratory infections [34]. However, in
all cases infected mice displayed enhanced bacterial growth in
their lungs, which we did not observe in our Chlamydia-infected
mice. This most likely reflects the ability of TLR2-deficient mice to
mount an adequate IFN-c response independent of TLR2
activation, and further suggests that the exaggerated inflammation
is related to downstream anti-inflammatory pathways.
Finally it is worth comparing our results in the murine
respiratory model for C. muridarum with the three published studies
on the related pathogen, C. pneumoniae, all of which used TLR2-
deficient mice. In the first report, the bacterial load in TLR2-
deficient mice infected with C. pneumoniae was unchanged, and the
inflammatory cytokine response in the lung was decreased [35].
Subsequently, two other groups reported similar findings with
regard to bacterial clearance in TLR2-deficient mice and they
reported no difference in lung inflammation [36,37]. It is difficult
to directly compare C. muridarum and C. pneumoniae models since
Figure 6. Intranasal infection with plasmid-cured strains of C. muridarum induces more extensive inflammatory changes in the lungs
compared to wild type C. muridarum infected mice. Mice were inoculated via the intranasal route with C. muridarum Nigg or one of the
plasmid-deficient mutant strains, CM972 or CM3.1, or mock infected with PBS, as described in the Methods. At seven days post infection, lungs were
removed and the tissue processed for routine H&E staining. Shown above are representative histopathological images from (A) uninfected mice, and
mice infected with (B) Nigg, (C) CM972, or (D) CM3.1. The dense, dark purple stain denotes the infiltrating PMNs, while the pale purple stain
represents edema. Original magnification 1006. This figure is representative of two independent experiments performed.
doi:10.1371/journal.pone.0020846.g006
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muridarum is a natural respiratory pathogen of mice that likely
evolved to infect this particular niche, and mice become
symptomatic with a significantly lower inoculum (3 logs) compared
to C. pneumoniae. The question remains as to which model more
closely represents human respiratory disease, and it is likely that
both models address different aspects of human infections from
chlamydia.
TLRs and other innate immune receptors play a critical role in
the innate immune response to pathogens, and the cooperation
between multiple cell types and the panel of receptors they express
maintains the balance between antimicrobial defenses and tissue
homeostasis. Our observations lead us to conclude that the role of
TLR2 in host defense is contextual, and that while TLR2
deficiency results in decreased virulence of infection in the genital
tract, it has the opposite effect in the lung. Thus, the response to a
pathogen at one mucosal surface may not necessarily predict the
response at a different mucosal site, an important consideration for
development of mucosal vaccines. A better understanding of the
cellular interactions and molecular signaling pathways activated
during infection at various mucosal surfaces is needed if the
development of mucosal vaccines is to move forward.
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